Noroxin, also known by its generic name norfloxacin, is a medication used to treat various bacterial infections. It is commonly prescribed for urinary tract infections (UTIs) and certain types of gastroenteritis. Noroxin works by stopping the growth of bacteria.
The Noroxin price is approximately £0.31 – £0.5 per pills. Depending on the size of the pack and the number of tablets inside (60 or 360 mg).
Noroxin contains norfloxacin as its active ingredient. Norfloxacin is a broad-spectrum antibiotic belonging to the fluoroquinolone class. It is effective in treating various bacterial infections by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription.
Noroxin is primarily indicated for urinary tract infections (UTIs) caused by susceptible strains of bacteria. Additionally, it is used to treat prostatitis, gonorrhea, and certain types of gastrointestinal infections. Noroxin is effective in eradicating bacteria such as Escherichia coli, Klebsiella pneumoniae, and Neisseria gonorrhoeae.
Noroxin is available in tablet form, with each tablet containing 400 mg of norfloxacin. The tablets are white to off-white, scored, and oblong in shape. They are designed for oral administration and should be swallowed whole with a sufficient quantity of water.
Noroxin should be taken either one hour before or two hours after meals to maximize absorption. It is essential to adhere to the prescribed dosage schedule to ensure optimal therapeutic efficacy. Skipping doses or prematurely discontinuing the medication can lead to bacterial resistance.
The usual adult dose for UTIs is 400 mg twice daily for 7 to 10 days. For uncomplicated gonorrhea, a single 800 mg dose is typically administered. In cases of prostatitis, the recommended dosage is 400 mg twice daily, continued for at least 28 days. Duration may vary based on infection severity and patient response.
Norfloxacin works by penetrating bacterial cells and inhibiting the activity of DNA gyrase and topoisomerase IV. These enzymes are crucial for the coiling and uncoiling of bacterial DNA, processes necessary for replication and transcription. Inhibition of these enzymes hampers bacterial DNA replication, leading to cell death.
Noroxin is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately one to two hours after oral administration. The bioavailability of norfloxacin is around 30-40%. Norfloxacin is modestly protein-bound and is primarily excreted unchanged in the urine, with an elimination half-life of approximately 3 to 4 hours.
Noroxin can interact with antacids containing magnesium or aluminum, as well as supplements containing calcium, iron, or zinc. These substances can form complexes with norfloxacin, reducing its absorption and efficacy. The medication should be taken at least two hours before or two hours after such products. Caution is also advised when co-administering with certain antiarrhythmic drugs, as they may affect heart rhythm.
Store Noroxin tablets at room temperature, away from moisture and direct sunlight. Keep the medication in its original container, tightly closed, to protect it from air and contaminants. Dispose of any unused medication in accordance with local regulations to prevent accidental ingestion or misuse.
Noroxin is contraindicated in patients with a known hypersensitivity to norfloxacin or other fluoroquinolones. It should not be used in individuals with a history of tendon disorders related to fluoroquinolone therapy. Severe caution is advised in patients with myasthenia gravis due to the risk of exacerbating muscle weakness.
Common side effects of Noroxin include nausea, diarrhea, headache, and dizziness. Less commonly, patients may experience insomnia, abdominal pain, or rash. Rare but serious side effects include tendon rupture, peripheral neuropathy, and CNS effects such as seizures or psychosis. Any unusual or severe reactions should be reported to a healthcare provider immediately.
Renal function should be monitored in patients with impaired renal function, as norfloxacin is primarily excreted by the kidneys. Monitoring liver enzymes may be necessary in patients with hepatic impairment or those receiving prolonged therapy. Regular assessment of therapeutic response and any adverse effects is essential during treatment.
Patients should be advised to take Noroxin exactly as prescribed, completing the full course of therapy even if symptoms improve. They should avoid taking the medication with dairy products or calcium-fortified juices. Patients should also be aware of the potential for photosensitivity and advised to use sunscreen and protective clothing when outdoors. Inform them to promptly report any signs of tendon pain, swelling, or inflammation.
Noroxin has demonstrated efficacy in clinical trials, showing significant bacteriological eradication and symptom resolution in patients with UTIs and prostatitis. It is particularly effective against several gram-negative bacteria, making it a valuable treatment option. Clinical guidelines often recommend it as a second-line therapy for uncomplicated UTIs.
Bacterial resistance to norfloxacin can occur, especially in areas with high usage of fluoroquinolones. Resistance mechanisms involve mutations in the target enzymes or efflux pumps. It is crucial to use Noroxin judiciously, prescribing it only when clearly indicated and following resistance surveillance data.
In patients with renal impairment, dose adjustments of Noroxin may be necessary. For those with creatinine clearance less than 30 mL/min, the recommended dosage is 400 mg once daily. Adjusting the dose helps prevent drug accumulation and reduces the risk of adverse effects. Regular renal function tests are advised during therapy.
Elderly patients may be more susceptible to Noroxin’s adverse effects, particularly tendonitis and tendon rupture. Careful monitoring and dose adjustments based on renal function are recommended. Fall risk should be assessed, and patients should be informed about the increased risk of musculoskeletal issues.
Noroxin falls under FDA Pregnancy Category C. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Norfloxacin can be excreted in breast milk, and caution is advised when administering to breastfeeding mothers. Alternatives may be considered based on the specific clinical scenario.
Noroxin offers distinct advantages, such as its broad-spectrum activity and effective penetration into the urinary tract tissues. It also exhibits limited cross-resistance with other antibiotic classes, making it a suitable option for certain resistant infections. Its twice-daily dosing regimen enhances patient compliance compared to more frequent dosing schedules.